CrushSCI.com
提供学术论文选刊润色服务
EXPERT OPINION ON EMERGING DRUGS 期刊封面 医学
返回期刊列表

Review Cycle Records

EXPERT OPINION ON EMERGING DRUGS

Taylor & Francis SCIE 非OA
2026新锐 3区2025中科院 4区2025 JCR Q2
150.1平均天数
91中位天数
29最短天数
420最长天数
252025发文量

Paper Review Records

全部论文审稿周期

14 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

336 天

Emerging biological drugs for the treatment of patients with metastatic HER2+ gastroesophageal adenocarcinomas

作者Jane E. Rogers; Ashley Horak; Alicia Kroll; Jaffer A. Ajani

作者单位1. U.T. M.D. Anderson Cancer Center; 2. U.T.M.D. Anderson Cancer Center

PDF源文件 DOI 网页
195 天

At the forefront of gene-based therapies in Dravet syndrome

作者Antonella Riva; Sara Di Gioacchino; Greta Volpedo; Beatrice Risso; Antonella De Lillo; Federico Zara; Antonio Falace; Pasquale Striano

作者单位1. University of Genoa; 2. IRCCS Istituto “Giannina Gaslini”, Full Member of ERN EpiCARE

PDF源文件 DOI 网页
29 天

σ 1 receptor agonists: the new trend or an emerging therapeutic option?

作者Tangui Maurice

作者单位1. University of Montpellier, EPHE, INSERM

PDF源文件 DOI 网页
236 天

Evaluating emerging amyloid-β centric drugs for the treatment of Alzheimer's disease

作者Madia Lozupone; Vittorio Dibello; Rodolfo Sardone; Roberta Zupo; Fabio Castellana; Ilaria Bortone; Luisa Lampignano; Michela Di Matteo; Giuseppe Moramarco; Flora Dellegrazie; Antonio Daniele; Vincenzo Solfrizzi; Francesco Panza

作者单位1. Local Health Authority of Bari; 2. University of Bari Aldo Moro; 3. University of Bari “Aldo Moro”; 4. University of Amsterdam and Vrije Universiteit Amsterdam; 5. Local Healthcare Authority of Taranto; 6. Local Healthcare Authority of Bari; 7. Catholic University of Sacred Heart; 8. IRCCS Fondazione Policlinico Universitario A. Gemelli

PDF源文件 DOI 网页
87 天

Obefazimod (ABX464) for moderate-to-severe Crohn’s disease: clinical development of a novel oral therapeutic approach

作者Sailish Honap; Axel Dignass; Vipul Jairath; Fernando Magro; Silvio Danese; Laurent Peyrin-Biroulet

作者单位1. St George’s University Hospitals NHS Foundation Trust; 2. King’s College London; 3. Goethe University; 4. Western University; 5. Faculdade de Medicina da Universidade do Porto; 6. IRCCS Ospedale San Raffaele; 7. McGill University Health Centre

PDF源文件 DOI 网页
77 天

Emerging treatment options for chronic obstructive pulmonary disease: a look into 2026 and beyond

作者Carolyn J. Wang; Clarus Leung; Don D. Sin

作者单位1. St. Paul’s Hospital; 2. The University of Western Australia; 3. University of British Columbia

PDF源文件 DOI 网页
66 天

Acute management of adult MOG antibody–associated disease: therapeutic choices and clinical outcomes

作者Edgar Carnero Contentti; Eoin P. Flanagan; Ethel Ciampi

作者单位1. Hospital Alemán; 2. INECO Neurociencias Oroño; 3. Mayo Clinic College of Medicine; 4. Pontificia Universidad Católica de Chile; 5. Red de Salud UC CHRISTUS; 6. Hospital Dr Sotero del Rio

PDF源文件 DOI 网页
48 天

Beyond triptans in menstrual migraine: the emerging role of CGRP-targeted therapies

作者Lanfranco Pellesi; Damiana Scuteri; Andrea Burgalassi; Alberto Chiarugi; Paolo Martelletti

作者单位1. University of Southern Denmark; 2. University “Magna Graecia” of Catanzaro; 3. Careggi University Hospital; 4. Unitelma Sapienza University of Rome

PDF源文件 DOI 网页
95 天

Emerging small molecules for ulcerative colitis: clinical advancements and trial insights

作者Cristina Lanzotti; Fabrizio Fanizzi; Ferdinando D’Amico; Alessandra Zilli; Federica Furfaro; Mariangela Allocca; Virginia Solitano; Clelia Cicerone; Sara Massironi; Tommaso Lorenzo Parigi; Laurent Peyrin-Biroulet; Silvio Danese

作者单位1. IRCCS San Raffaele Hospital; 2. Vita-Salute San Raffaele University; 3. Istituti Ospedalieri Bergamaschi; 4. INFINY Institute, CHRU Nancy

PDF源文件 DOI 网页
135 天

Emerging claudin-18.2 antagonists in the treatment of biliary tract cancer

作者Daniel Neureiter; Dino Bekric; Christian Mayr; Tobias Kiesslich; Matthias Ocker

作者单位1. Paracelsus Medical University/University Hospital Salzburg (SALK); 2. Cancer Cluster Salzburg; 3. Paracelsus Medical University; 4. University Clinics Salzburg, Paracelsus Medical University; 5. Campus Charité Mitte, Charité University Medicine Berlin; 6. EO Translational Insights Consulting GmbH; 7. Tacalyx GmbH

PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿96.4 天

中位数77 天

Contact CrushSCI

联系 CrushSCI

扫码添加微信,或留下手机号/微信号,我们将与你确认稿件阶段、编辑需求和投稿计划。

当前选择:论文编辑服务

也可以预留联系方式

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。